EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudie

Biatrial Versus Left Atrial Maze Ablation During Cardiac Valve Surgery for Persistent Atrial Fibrillation: The ABLATION Trial

Zhongchen Li iD, Chunyu Yu iD, Haojie Li, Yang Wang iD, Yongfeng Shao iD, Jinping Liu iD, Jianglong Hou iD, Zhi Fang iD, Zhi Lin, Hui Xiong, Huiming Guo iD, Liang Ma iD und 23 weitere

Circulation · 17.11.2026 · 154 (20) · 2001-2010

DOI: 10.1161/circulationaha.126.083005 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Circulation, erschienen am 17.11.2026. Verfasst von Zhongchen Li und 34 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Department of Cardiovascular Surgery (…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Maze Procedure, Catheter Ablation, Heart Atria. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Guidelines recommend concomitant surgical ablation during cardiac surgery in patients with atrial fibrillation (AF). However, the optimal lesion set remains uncertain, with ongoing debate regarding the relative benefits and risks of biatrial versus left atrial (LA) maze ablation. METHODS: In this multicenter, randomized, single-blind trial, patients with persistent or long-standing persistent AF undergoing rheumatic mitral valve surgery, with or without concomitant cardiac surgical procedures, were randomly assigned in a 1:1 ratio to undergo biatrial or LA maze ablation. The biatrial group underwent a complete Cox-Maze IV procedure; the LA group received a left-sided maze lesion set. To ensure standardization and consistency of the ablation procedures, surgeons underwent pretrial training and certification, and all procedures were videorecorded and centrally reviewed. The primary outcome was freedom from atrial tachyarrhythmias lasting >30 seconds without antiarrhythmic drugs within 12 months. The key secondary end point was freedom from permanent pacemaker implantation. RESULTS: All 323 randomized patients were included in the intention-to-treat analysis (mean age, 56.5 years; 72.1% women; mean LA diameter, 51.9 mm). At 12 months, 78.7% of patients (129 of 164) in the biatrial group and 68.6% (109 of 159) in the LA group were free from atrial tachyarrhythmias (adjusted difference, 10.7% [1-sided lower 95% CI, 3%]; P =0.01). Freedom from permanent pacemaker implantation was noted in 97.0% (159 of 164) of the biatrial group and 98.1% (156 of 159) of the LA group, meeting the predefined noninferiority criterion with a margin of −5% (adjusted difference, –1.1% [1-sided lower 95% CI, –3.9%]; P noninferiority =0.01). CONCLUSIONS: Among patients with persistent or long-standing persistent AF undergoing rheumatic cardiac valve surgery, biatrial maze ablation was superior to LA maze ablation in reducing recurrent atrial tachyarrhythmias, while maintaining noninferiority with respect to permanent pacemaker implantation. These findings provide direct evidence to inform lesion-set selection for surgical ablation during cardiac surgery. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05021601.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationMaze ProcedureCatheter AblationHeart AtriaCardiac Surgical ProceduresMitral ValveHumansFemaleMaleMiddle AgedSingle-Blind MethodAgedTreatment Outcome

Stichwörter der Autor:innen

atrial fibrillationcardiac surgical proceduresmaze procedurerheumatic heart disease

Autor:innen und Institutionen

  • National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Department of Cardiovascular Surgery (Z. Li, C.Y., H.L., S.W., X.H., F.X., X.Y., S.L., Y.Y., H.Z., Y. Zhang,…
  • Medical Research & Biometrics Center, National Center for Cardiovascular Diseases (Y.W.), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College…
  • Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China (Y.S.).
  • Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University, China (J.L.).
  • Hubei Provincial Engineering Research Center of Minimally Invasive Cardiovascular Surgery, Wuhan, China (J.L.).
  • Wuhan Clinical Research Center for Minimally Invasive Treatment of Structural Heart Disease, China (J.L.).

ORCID-Profile: Zhongchen Li, Chunyu Yu, Yang Wang, Yongfeng Shao, Jinping Liu, Jianglong Hou, Zhi Fang, Huiming Guo, Liang Ma, Shuiyun Wang, Fei Xu, Ye Kong, Heng Zhang, Zhe Zheng

Zitieren

APA

Li, Z., Yu, C., Li, H., Wang, Y., Shao, Y., Liu, J., Hou, J., Fang, Z., Lin, Z., Xiong, H., Guo, H., Ma, L., Li, F., Wang, X., Wang, S., Hu, X., Xu, F., Yuan, X., Cheng, Z., …, & Zheng, Z. (2026). Biatrial Versus Left Atrial Maze Ablation During Cardiac Valve Surgery for Persistent Atrial Fibrillation: The ABLATION Trial. Circulation, 154(20), 2001-2010. https://doi.org/10.1161/circulationaha.126.083005

Vancouver

Li Z, Yu C, Li H, Wang Y, Shao Y, Liu J, et al. Biatrial Versus Left Atrial Maze Ablation During Cardiac Valve Surgery for Persistent Atrial Fibrillation: The ABLATION Trial. Circulation. 2026;154(20):2001-2010. doi:10.1161/circulationaha.126.083005

BibTeX
@article{Li2026,
  author = {Li, Zhongchen and Yu, Chunyu and Li, Haojie and Wang, Yang and Shao, Yongfeng and Liu, Jinping and Hou, Jianglong and Fang, Zhi and Lin, Zhi and Xiong, Hui and Guo, Huiming and Ma, Liang and Li, Fei and Wang, Xiaoqi and Wang, Shuiyun and Hu, Xiaopeng and Xu, Fei and Yuan, Xin and Cheng, Zhaoyun and Zhao, Ziniu and Wang, Jue and Liu, Sheng and Yang, Yan and Kong, Ye and Zhou, Qing and Pan, Jun and Liu, Zhigang and Du, Yukui and Chen, Xin and Tian, Hai and Zhang, Heng and Zhang, Ying and Zhao, Yan and Liu, Liming and Zheng, Zhe},
  title = {Biatrial Versus Left Atrial Maze Ablation During Cardiac Valve Surgery for Persistent Atrial Fibrillation: The ABLATION Trial},
  journal = {Circulation},
  year = {2026},
  volume = {154},
  number = {20},
  pages = {2001--2010},
  doi = {10.1161/circulationaha.126.083005}
}
Kostenlos starten →